The Oncology Institute, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $33.6M | $49.7M | $33.5M | $14.0M | $115.2M | $900.0K | $2.4M |
| Accounts Receivable | $59.0M | $48.3M | $42.4M | $39.8M | $20.0M | $17.1M | — |
| Inventory | $16.9M | $10.0M | $13.7M | $9.3M | $6.4M | $4.4M | — |
| Total Current Assets | $112.7M | $112.4M | $143.5M | $130.4M | $154.1M | $29.7M | $25.0K |
| Property, Plant & Equipment | $10.7M | $11.9M | $10.9M | $8.5M | $4.2M | $2.1M | — |
| Goodwill | $7.2M | $7.2M | $7.2M | $21.4M | $26.6M | $14.2M | — |
| Intangible Assets (Excl. Goodwill) | $11.0M | $14.8M | $17.9M | $18.0M | $18.2M | $19.5M | — |
| Total Assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M | $65.7M | $50.0K |
| Liabilities | |||||||
| Accounts Payable | $43.2M | $24.3M | $14.4M | $9.4M | $15.6M | $12.6M | — |
| Total Current Liabilities | $71.0M | $52.2M | $34.8M | $29.7M | $29.8M | $28.6M | $27.3K |
| Long-Term Debt | $77.4M | $93.1M | $86.8M | $80.6M | $0 | $6.6M | — |
| Total Liabilities | $180.4M | $169.1M | $152.2M | $138.5M | $99.3M | $37.6M | $27.3K |
| Stockholders' Equity | |||||||
| Retained Earnings | $-271.4M | $-210.8M | $-146.2M | $-63.1M | $-63.2M | $-52.3M | $-2.3K |
| Total Stockholders' Equity | $-15.7M | $3.6M | $57.0M | $123.2M | $104.2M | $28.1M | $42.2M |